3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Barrett Esophagus
1
Adenocarcinoma
1
Interventions
Endoscopy, Digestive System
5
Aspirin
3
YF 476
2
Narrow Band Imaging
2
Esomeprazole
2
Dexlansoprazole
2
Biopsy
2
omeprazole, sodium bicarbonate drug combination
1
chlorhexidine gluconate
1
Ursodeoxycholic Acid
1
Tomography, Optical Coherence
1
Sunitinib
1
Specimen Handling
1
Radiofrequency Ablation
1
Proton Pump Inhibitors
1
Photochemotherapy
1
Omeprazole
1
Metformin
1
Genes, BRCA1
1
Endoscopy
1
Endoscopic Mucosal Resection
1
Endoscopes
1
Docosahexaenoic Acids
1
Dihematoporphyrin Ether
1
Diagnostic Imaging
1
Cryosurgery
1
Contraceptive Devices, Female
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Barrett Esophagus
×
Diagnostic Imaging
×
Clear all
NCT00795184
2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA
Completed
122 enrolled
5 charts